Distinguishing between viral and bacterial sepsis infections to fight AMR
16 Jan 2025
The consistent use of antibiotics has led to the emergence of antibiotic resistance. Despite this knowledge, antibiotics are still being over-prescribed, which is an issue that needs addressing. Dr. Jean Patel introduces an immunoassay capable of determining whether infections are viral or bacterial in just 15 minutes. Discover how the MeMed BV® test can provide more targeted solutions and offer a deeper understanding of the patient's condition for better infection recognition.
About the company
Beckman Coulter Diagnostics
Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represents approximately 78 percent of the company s 2007 annual revenue of $2.76 billion. For more information, visit www.beckmancoulter.com.
